31![Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed] Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed]](https://www.pdfsearch.io/img/a71910094d8f8f3b306a1cdfd61b9d42.jpg) | Add to Reading ListSource URL: www.kdheks.govLanguage: English - Date: 2013-01-01 09:43:57
|
---|
32![Janssen Biotech Inc. Sharps Disposal Plan Janssen Biotech Inc. Sharps Disposal Plan](https://www.pdfsearch.io/img/5a93fb529441c0f7032c10c694e2833c.jpg) | Add to Reading ListSource URL: www.calrecycle.ca.govLanguage: English - Date: 2014-07-17 18:08:51
|
---|
33![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SIMPONI® (golimumab) safely and effectively. See full prescribing information for SIMPONI. SIMPONI (golimumab) Inje HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SIMPONI® (golimumab) safely and effectively. See full prescribing information for SIMPONI. SIMPONI (golimumab) Inje](https://www.pdfsearch.io/img/8f89582d1c6a46ddd56a9df07972e79f.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2010-08-10 12:14:47
|
---|
34![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SIMPONI® ARIATM safely and effectively. See full prescribing information for SIMPONI ARIA. SIMPONI ARIA (golimumab) HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SIMPONI® ARIATM safely and effectively. See full prescribing information for SIMPONI ARIA. SIMPONI ARIA (golimumab)](https://www.pdfsearch.io/img/fefd4047e5bdccded79a184c7f058ade.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-02-13 12:50:12
|
---|
35![September 20, 2012 Press Release Mitsubishi Tanabe Pharma Corporation Launch of September 20, 2012 Press Release Mitsubishi Tanabe Pharma Corporation Launch of](https://www.pdfsearch.io/img/1381ce23de30debbe9e8a58e4ecd25d6.jpg) | Add to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English - Date: 2012-09-24 21:13:30
|
---|
36![Friday, February 1, 2013 from 6:30pm to 7:15pm [Attendees] Kenichi Yanagisawa, Board Director and Senior Managing Executive Officer, Division Manager of Sales & Marketing Division Kenkichi Kosakai, Board Director and Ma Friday, February 1, 2013 from 6:30pm to 7:15pm [Attendees] Kenichi Yanagisawa, Board Director and Senior Managing Executive Officer, Division Manager of Sales & Marketing Division Kenkichi Kosakai, Board Director and Ma](https://www.pdfsearch.io/img/51bd4101059cee362a89c882c79e630c.jpg) | Add to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English - Date: 2013-02-08 00:41:53
|
---|
37![Imprimer Effacer DEMANDE D’AUTORISATION DE PAIEMENT Adalimumab (HumiraMC), étanercept (EnbrelMC), golimumab (SimponiMC) Imprimer Effacer DEMANDE D’AUTORISATION DE PAIEMENT Adalimumab (HumiraMC), étanercept (EnbrelMC), golimumab (SimponiMC)](https://www.pdfsearch.io/img/b1b9a15c593b54cf096dbe0a25d8ad17.jpg) | Add to Reading ListSource URL: www.ramq.gouv.qc.caLanguage: French - Date: 2014-07-21 11:01:36
|
---|
38![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SIMPONI safely and effectively. See full prescribing information for SIMPONI. SIMPONI (golimumab) injection, for sub HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SIMPONI safely and effectively. See full prescribing information for SIMPONI. SIMPONI (golimumab) injection, for sub](https://www.pdfsearch.io/img/2ef011ed437ff07ce2319900a12cdd3a.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2013-11-15 13:27:29
|
---|
39![SPECIAL AUTHORIZATION REQUEST PSORIATIC ARTHRITIS Fax requests to[removed]OR mail requests to PEI Pharmacare, P.O. Box 2000, Charlottetown, PE, C1A 7N8 HIGH-COST DRUG PATIENT APPLICATION ALSO REQUIRED PRIOR TO CO SPECIAL AUTHORIZATION REQUEST PSORIATIC ARTHRITIS Fax requests to[removed]OR mail requests to PEI Pharmacare, P.O. Box 2000, Charlottetown, PE, C1A 7N8 HIGH-COST DRUG PATIENT APPLICATION ALSO REQUIRED PRIOR TO CO](https://www.pdfsearch.io/img/96f0a975b82b31145fcf9ea0604a97db.jpg) | Add to Reading ListSource URL: www.gov.pe.caLanguage: English - Date: 2011-05-12 10:41:06
|
---|
40![Simponi (golimumab) label Simponi (golimumab) label](https://www.pdfsearch.io/img/91274c7df1617616cf9b522719c08de3.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2012-03-15 14:14:14
|
---|